North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,310 Jan 1 – Oct 27, 2026
- Disclosed funding
- $252.1B 1915 disclosed amounts
- Median round
- $23.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| VA Vista AICompany profile Develops AI-powered MRI automation software for hospitals and imaging centers Develops AI-powered MRI automation software for hospitals and imaging centers | $29.5M | Series B | Healthtech | United States | Investors | |
| SA Building a unified robotics foundation model for controlling robots | $1.4B | Undisclosed | AI | United States | Investors | |
| V Develops full-stack voice AI platform for enterprises | $5.5M | Seed | AI | United States | Investors | |
| T TitlCompany profile Automates title search and continuously monitors for changes that can impact ownership Automates title search and continuously monitors for changes that can impact ownership | $2.5M | Seed | Proptech | United States | Investors | |
| PH Pillr HealthCompany profile Provides software and analytics to optimize pharmacy operations for hospitals and health systems Provides software and analytics to optimize pharmacy operations for hospitals and health systems | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
 AmperonCompany profile Amperon provides electricity-demand, renewable-generation and power-price forecasts for energy-market participants. Amperon provides electricity-demand, renewable-generation and power-price forecasts for energy-market participants. | Undisclosed | Undisclosed | Climate tech | United States | Investors | |
| CT Caldera TherapeuticsCompany profile Develops bispecific antibody CLD-423 for inflammatory bowel disease Develops bispecific antibody CLD-423 for inflammatory bowel disease | $37.5M | Series A1Series A | Biotech | United States | Investors | |
| Q QuadricCompany profile Quadric is a licensor of fully programmable general-purpose AI inference processor IP Quadric is a licensor of fully programmable general-purpose AI inference processor IP | $30M | Series CSeries C+ | AI | United States | Investors | |
| d depthfirstCompany profile Develops AI-native security platform for software vulnerability detection and fix recommendations Develops AI-native security platform for software vulnerability detection and fix recommendations | $40M | Series A | Cybersecurity | United States | Investors | |
| AI Atomic InsightsCompany profile Provides money-movement and workflow automation tools for RIAs and family offices Provides money-movement and workflow automation tools for RIAs and family offices | $10M | Seed | Fintech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
134rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
98rounds19led - 3General Catalyst
Provision Labs, Tractian, Different
71rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.